Stage Shift Tied to Decreased Population Mortality in NSCLC

Diagnostic shift from later-stage to earlier-stage disease may have implications for evaluation of treatments and mortality outcomes

Efficacy and Safety of Afatinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with EGFR Mutations: A Meta-Analysis of Real-World Evidence

Positive and Suspicious Findings in Clinical CT Lung Cancer Screening

Analysis of screening results and risk factors of high-risk populations of lung cancer in Nanchang city from 2018 to 2019

Crizotinib versus Alectinib for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Leukocyte Count as a Predictor of Breast, Colorectal, Endometrial, and Lung Cancer and Mortality in Postmenopausal Women: A Prospective Study

Surgical Procedure Selection for Stage I Lung Cancer

Blood Metabolomics May Detect Early Lung Cancer

Predictive models based on comparison of serum metabolomic patterns for patients at time of lung cancer diagnosis and matched controls

ALA Releases Fourth Annual State of Lung Cancer Report

National five-year survival rate for lung cancer has increased to 23.7 percent, but disparities persist for people of color

Early lung carcinogenesis and tumor microenvironment observed by single-cell transcriptome analysis